1. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348(2):138-150.
2. Oberholzer A, Oberholzer C, Moldawer LL: Sepsis syndromes: understanding the role of innate and acquired immunity. SHOCK 2001, 16(2):83-96.
3. Shubin NJ, Monaghan SF, Ayala A: Anti-inflammatory mechanisms of sepsis. Contrib Microbiol 2011, 17:108-124.
4. Ueha S, Shand FH, Matsushima K: Myeloid cell population dynamics in healthy and tumor-bearing mice. INT IMMUNOPHARMACOL 2011, 11(7):783-788.
5. Cuenca AG, Delano MJ, Kelly-Scumpia KM, Moreno C, Scumpia PO, Laface DM, Heyworth PG, Efron PA, Moldawer LL: A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. MOL MED 2011, 17(3-4):281-292.
6. Brudecki L, Ferguson DA, McCall CE, El GM: Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. INFECT IMMUN 2012, 80(6):2026-2034.
7. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V: Myeloid-derived suppressor cell heterogeneity and subset definition. CURR OPIN IMMUNOL 2010, 22(2):238-244.
8. Gabrilovich DI, Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. NAT REV IMMUNOL 2009, 9(3):162-174.
9. Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD: Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. IMMUNITY 2008, 29(2):306-317.
10. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P et al: Identification of splenic reservoir monocytes and their deployment to inflammatory sites. SCIENCE 2009, 325(5940):612-616.
11. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock--a review of laboratory models and a proposal. J SURG RES 1980, 29(2):189-201.
12. Spiller F, Costa C, Souto FO, Vinchi F, Mestriner FL, Laure HJ, Alves-Filho JC, Freitas A, Rosa JC, Ferreira SH et al: Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice. Am J Respir Crit Care Med 2011, 183(7):922-931.
13. Sheng Z, Yao Y, Li Y, Yan F, Huang J, Ma G: Bradykinin preconditioning improves therapeutic potential of human endothelial progenitor cells in infarcted myocardium. PLOS ONE 2013, 8(12):e81505.
14. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. CRIT CARE MED 2007, 35(5):1244-1250.
15. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK: Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. CRIT CARE MED 2012, 40(3):754-761.
16. Gaieski DF, Edwards JM, Kallan MJ, Carr BG: Benchmarking the incidence and mortality of severe sepsis in the United States. CRIT CARE MED 2013, 41(5):1167-1174.
17. Gamkrelidze M, Intskirveli N, Vardosanidze K, Goliadze L, Chikhladze K, Ratiani L: Myocardial dysfunction during septic shock (review). Georgian Med News 2014(237):40-46.
18. Fan TT, Feng XY, Yang YZ, Gao F, Liu Q: Downregulation of PI3K-gamma in a mouse model of sepsis-induced myocardial dysfunction. CYTOKINE 2017, 96:208-216.
19. Xia S, Sha H, Yang L, Ji Y, Ostrand-Rosenberg S, Qi L: Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity. J BIOL CHEM 2011, 286(26):23591-23599.
20. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC: Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. CLIN CANCER RES 2007, 13(2 Pt 2):721s-726s.
21. Brudecki L, Ferguson DA, McCall CE, El GM: Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. INFECT IMMUN 2012, 80(6):2026-2034.
22. Huang J, Lv G, Min Y, Yang L, Lin PC: Intravenous administration of Gr-1+CD11b+ myeloid cells increases neovascularization and improves cardiac function after heart infarction. INT J CARDIOL 2013, 168(2):1702-1705.
23. Wei WC, Lin SY, Lan CW, Huang YC, Lin CY, Hsiao PW, Chen YR, Yang WC, Yang NS: Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis. Sci Rep 2016, 6:36663.
24. Zhang Y, Li H, Zhao G, Sun A, Zong NC, Li Z, Zhu H, Zou Y, Yang X, Ge J: Hydrogen sulfide attenuates the recruitment of CD11b(+)Gr-1(+) myeloid cells and regulates Bax/Bcl-2 signaling in myocardial ischemia injury. Sci Rep 2014, 4:4774.
25. Yao T, Lu W, Zhu J, Jin X, Ma G, Wang Y, Meng S, Zhang Y, Li Y, Shen C: Role of CD11b+Gr-1+ myeloid cells in AGEs-induced myocardial injury in a mice model of acute myocardial infarction. Int J Clin Exp Pathol 2015, 8(3):3238-3249.
26. Cobbold SP: The mTOR pathway and integrating immune regulation. IMMUNOLOGY 2013, 140(4):391-398.
27. Zhang C, Wang S, Li J, Zhang W, Zheng L, Yang C, Zhu T, Rong R: The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury. CELL DEATH DIS 2017, 8(3):e2695.
28. Zhang Y, Bi Y, Yang H, Chen X, Liu H, Lu Y, Zhang Z, Liao J, Yang S, Chu Y et al: mTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury. J Leukoc Biol 2014, 95(6):961-970.
29. Temiz-Resitoglu M, Kucukkavruk SP, Guden DS, Cecen P, Sari AN, Tunctan B, Gorur A, Tamer-Gumus L, Buharalioglu CK, Malik KU et al: Activation of mTOR/IkappaB-alpha/NF-kappaB pathway contributes to LPS-induced hypotension and inflammation in rats. EUR J PHARMACOL 2017, 802:7-19.
30. Dando I, Cordani M, Donadelli M: Mutant p53 and mTOR/PKM2 regulation in cancer cells. IUBMB LIFE 2016, 68(9):722-726.
31. Sung JY, Lee KY, Kim JR, Choi HC: Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16. EXP GERONTOL 2018, 109:51-58.
32. Rosso A, Balsamo A, Gambino R, Dentelli P, Falcioni R, Cassader M, Pegoraro L, Pagano G, Brizzi MF: p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J BIOL CHEM 2006, 281(7):4339-4347.
33. Engeland K: Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. CELL DEATH DIFFER 2018, 25(1):114-132.
34. Guo JN, Tian LY, Liu WY, Mu J, Zhou D: Activation of the Akt/mTOR signaling pathway: A potential response to long-term neuronal loss in the hippocampus after sepsis. NEURAL REGEN RES 2017, 12(11):1832-1842.